FindTrial
Sign In

Role of Durva and Haridra lepa in Dadru Roga.

A pharmaco-therapeutic study of Durva (Cynodon dactylon) and Haridra (Curcuma longa) lepa in Dadru roga w.s.r to Tinea. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099255
Enrollment
20
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Govt. Ayurvedic College and Hospital
Lead Sponsor
myself
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical feature of Dadru Kustha will be included. Patient have infected with tinea.

Exclusion criteria

Exclusion criteria: Patient suffering from diseases like AIDS, Cancer, TB, etc. Patient having open wound, diabetic wound and have any active infections.

Design outcomes

Primary

MeasureTime frame
To evaluate the therapeutics role of Durva and Haridra lepa in Dadru. 2. Compilation of information regarding Durva and Haridra lepa in Dadru from Ayurvedic classics, modern text and scientific article. 3. Pharmacological and Pharmacognostical study of Durva and Haridra lepa.Timepoint: 4 weeks—

Secondary

MeasureTime frame
CLINICAL IMPROVEMENT IN DADRU PATIENTS.Timepoint: 120 DAYS.—

Countries

India

Contacts

Public ContactMAHENDRA PRASAD SINGH

Govt. Ayurvedic College, Patna

mahendrakiran1959@gmail.com9431040125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026